House bill · H.R. 9682 (119th Congress)
Cure Hepatitis C Act of 2026
U.S. House of Representatives
Sponsor: Mariannette Miller-Meeks (U.S. Representative, IA-1, Republican)
Following needs an Agora account. You will sign in first, then come back to this page.
From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data
Summary
Cure Hepatitis C Act of 2026 This bill establishes programs and requirements to provide free medications to treat hepatitis C in certain high-risk or vulnerable populations. It also establishes grants and other resources to support testing and treatment for hepatitis C. The bill provides funding for FY2027 to implement these provisions. The Department of Health and Human Services (HHS) must enter into a five-year purchasing contract with manufacturers of drugs that treat hepatitis C so that eligible individuals may receive the drugs without cost-sharing. Eligible individuals are those diagnosed with hepatitis C who are (1) enrolled in Medicaid or the Children’s Health Insurance Program (CHIP), (2) confined to federal, state, or local correctional facilities (or were released and began treatment there), (3) uninsured, or (4) receiving health care through the Indian Health Service. State Medicaid and CHIP programs and state and local correctional facilities may opt into the program; participation is mandatory for federal correctional facilities and the Indian Health Service. HHS must award grants to certain entities, including states, public health organizations, and correctional facilities, to support the coordination and provision of screening, treatment, and supportive services for the affected populations. The bill also allows Medicare beneficiaries to receive hepatitis C drugs without cost-sharing from 2028-2032.
Summary from the Congressional Research Service. How we handle summaries
Where it stands
Assigned to a committee for review.
- Introduced
- In committee
- Up for a vote
- Passed one chamber
- Passed
- Enacted
Committee
House Committee on Energy and Commerce · U.S. House of Representatives
Your position on this bill
Choose the position closest to yours. You'll sign in or create an account to save it.
Cosponsors
3
Cosponsors listed on Congress.gov, shown A to Z.
- Democratic2
- Republican1
This bill has cosponsors from more than one party.
Shown in neutral colors by design; Agora is non-partisan.
Related bills
As identified by Congress.gov.
Full history
- Jul 14, 2026
Introduced
Introduced in House
U.S. House of Representatives
- Jul 14, 2026
Introduced
Introduced in U.S. House
U.S. House
- Jul 14, 2026
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jul 14, 2026
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jul 14, 2026
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Read the record
- Read on Congress.gov (opens in a new tab) The official record on Congress.gov.